informa
/
Risk
News

Anchiva Delivers 800,000 Signatures

Rapid RxLabs is now delivering over 800,000 signatures to detect and prevent malware from entering enterprise networks

SANTA CLARA, Calif. -- Anchiva Systems, Inc., a leading provider of Web security appliances for the enterprise, today announced its research lab, Rapid RxLabs, is now delivering over 800,000 signatures to detect and prevent malware from entering enterprise networks. Anchiva has a network of “global honeypots”, which collect viruses and a range of malware that are continuously monitored enabling frequent multiple updates daily to the signature base, providing its customers with the most complete web security threat response on the market today.

As malware threats continue to rise, such as the recent “Storm” Trojan, there is a need to inspect web traffic for malware. The general public by now has learned to be more careful about opening e-mail attachments. Unfortunately, the same cannot be said about clicking on URLs in e-mails, IMs, and websites. Web born threats need to be identified and addressed quickly to keep networks and individual computers safe. Anchiva’s continuously monitoring of web traffic and timely signature updates allows Anchiva to stay ahead of these web delivered attacks.

Anchiva’s Web Security Appliances have the ability to store more than one million signatures and currently hold over 800,000 malware signatures for long lasting protection against spyware and other malware with long lifecycles. Developed around Anchiva’s RapidRX ASIC high-speed data inspection engine and patent-pending malware identification techniques, Anchiva’s architecture scales to near gigabit rates and ensures Internet traffic flowing in and out of corporate networks is secure, without impacting performance. Designed for enterprise organizations and service providers, Anchiva’s Web Security Appliances deliver a distinctive solution that scans the volumes of inbound and outbound messages passing through network infrastructures to ensure business applications continue running as usual.

With the increase in Web 2.0 applications and technologies in the enterprise, and the potential financial rewards hackers can gain, enterprises are looking to protect their networks at both inbound and outbound entry points. Security solutions available today need to have in-depth, application-centric, scanning and filtering capabilities to protect vital data. Anti-virus and anti-spyware signatures need to be updated frequently to protect companies against all threats while maintaining the pace of business. Having a security solution that addresses a complete range of security threats as well as performance needs is crucial to mission-critical, optimal business operations. Anchiva not only addresses these issues and threats, but does so at nearly 3 times faster than traditional software solutions and has a comprehensive signature database that is updated daily with new malware signatures.

Anchiva RapidRX Labs is one of the leading malware, anti-virus and vulnerability research organizations in the world, engaging the world's top researchers around the world. Anchiva RapidRX Labs combines world-class malicious code and anti-virus research with intrusion prevention and vulnerability expertise.

“As we continue to evaluate the threats coming in to our Rapid RX Labs, we are seeing a tremendous increase in Web-borne malware,” said Samuel Chen, Chief Technology Officer of Anchiva Systems. “In fact, last month we saw a greater increase in threats via Web-borne malware than Email threats.”

Anchiva Systems Inc.

Recommended Reading:
Editors' Choice
Kirsten Powell, Senior Manager for Security & Risk Management at Adobe
Joshua Goldfarb, Director of Product Management at F5